Home
JNJInnovation

JNJInnovation Market Share Analysis for June 2026

Healthcare innovation wherever it originates.

Health > Biotechnology and Pharmaceuticals

Domainjnjinnovation.com

Year Founded2013

Employees201 - 500

Annual Revenue$75M - $100M

JNJInnovation

JNJInnovation (including company regionals)

jnjinnovation.com

See more website traffic and engagement information

JNJInnovation Revenue up to June 2026 is 75M - 100M

revenue generated by JNJInnovation top domains

JNJInnovation top domains revenue over 3 years

Revenue for JNJInnovation top domains

jnjinnovation.com75M - 100M

See more with Sales Intelligence

Total visits to JNJInnovation's top domains

Understand JNJInnovation market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

jnjinnovation.com43.3K

See more with Sales Intelligence

Avg. visit duration in JNJInnovation's top domains

Analyze JNJInnovation engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

jnjinnovation.com00:00:42

See more with Sales Intelligence

Avg. pageviews on JNJInnovation's top domains

See how JNJInnovation keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

jnjinnovation.com2.23

See more with Sales Intelligence

JNJInnovation top competitors by domain

Top similar sites in June 2026, ranked by their affinity

jnj.comCompany NameJNJ - Johnson HallEmployees> 10001HQUnited States, New Jersey, New BrunswickAnnual revenue$2M - $5MTotal visits2.5MHealth > Health - Other

Top technologies used by JNJInnovation

These are the website technologies, by industry, used by JNJInnovation top domains

Advertising (14)

DoubleClick

Content Management System (3)

Drupal

Conversion & Analytics (3)

Google Analytics

Email Services (3)

MailChimp

More Technologies

8

See all

News & Signals from JNJInnovation

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsJnjinnovation invested into CereVasc, LLC $85M in Series C on Jun 4th '26.Cerevasc announced today it has successfully completed the initial closing of an US$85 million Series C financing led by Piper Sandler Merchant Banking with participation from Johnson & Johnson (J&J) Innovation, and Medtronic, along with existing investors Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds.

NewsIglesias leaves Innovation as Quality Program Leader.Earlier in his career, from 2012 to 2016, Mr. Iglesias served as the Quality Program Leader at Janssen Healthcare Innovation, part of Janssen Pharmaceutical Companies of Johnson & Johnson in San Diego, California.

NewsInnovation attends event BIO KOREA 2025.Reflecting on the successes and challenges experienced over the last twelve months, critical milestones were celebrated at JLABS Korea's 1-year anniversary during BIO KOREA 2025, setting the stage for an even more ambitious future.